Table 1 Patient characteristics (FIGO stage, grading) and type of hypoglycemic drug
Endometrial cancer (n = 86) | |||||
|---|---|---|---|---|---|
Metformin in monotherapy | Metformin + other drugs | Insulin in monotherapy | Sulfonylurea derivatives | Non- diabetics (control) | |
(n = 22) | (n = 10) | (n = 10) | (n = 6) | (n = 38) | |
FIGO I | 19 | 9 | 8 | 6 | 32 |
FIGO II-IV | 3 | 1 | 2 | 0 | 6 |
G1 | 8 | 6 | 6 | 3 | 23 |
G2 | 13 | 3 | 3 | 3 | 11 |
G3 | 1 | 1 | 1 | 0 | 4 |